Tandlægeholdingselskabet Anders Grønbeck ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  24.1% 20.8% 21.7% 25.8% 23.2%  
Credit score (0-100)  3 4 4 2 4  
Credit rating  B B B B B  
Credit limit (kDKK)  -0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  910 0 0 0 0  
Gross profit  -15.7 -59.3 -65.3 -32.2 -9.5  
EBITDA  -926 -291 -609 -36.0 -9.5  
EBIT  -926 -291 -609 -36.0 -9.5  
Pre-tax profit (PTP)  -14.2 306.1 50.8 -36.0 -9.8  
Net earnings  -14.2 255.0 38.9 -36.0 -9.8  
Pre-tax profit without non-rec. items  -925 306 50.8 -36.0 -9.8  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  -10.1 245 284 83.9 59.1  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  533 328 328 94.0 65.1  

Net Debt  -72.7 -149 -206 -86.0 -60.9  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  910 0 0 0 0  
Net sales growth  0.0% -100.0% 0.0% 0.0% 0.0%  
Gross profit  -15.7 -59.3 -65.3 -32.2 -9.5  
Gross profit growth  51.9% -277.9% -10.1% 50.7% 70.5%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  533 328 328 94 65  
Balance sheet change%  24.0% -38.4% 0.0% -71.4% -30.7%  
Added value  -926.1 -290.9 -609.1 -36.0 -9.5  
Added value %  -101.7% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 -1.0 0.0 0.0 0.0  
EBIT trend  -4.0 -5.0 -5.0 -5.0 -5.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  -101.7% 0.0% 0.0% 0.0% 0.0%  
EBIT %  -101.7% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  5,898.1% 490.2% 932.4% 111.6% 100.0%  
Net Earnings %  -1.6% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  -1.6% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  -101.6% 0.0% 0.0% 0.0% 0.0%  
ROA %  -190.1% 70.3% 16.5% -16.8% -11.6%  
ROI %  -22,825.6% 250.1% 20.5% -19.3% -12.9%  
ROE %  -5.3% 65.6% 14.7% -19.6% -13.7%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  -1.9% 74.6% 86.5% 89.3% 90.8%  
Relative indebtedness %  59.6% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  51.7% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  7.9% 51.3% 33.9% 239.1% 641.2%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  2.6% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  0.2 2.4 5.8 9.4 10.9  
Current Ratio  0.2 2.4 5.8 9.4 10.9  
Cash and cash equivalent  72.7 149.1 206.2 86.0 60.9  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  13.2% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -422.4 115.9 213.9 83.9 59.1  
Net working capital %  -46.4% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  910 0 0 0 0  
Added value / employee  -926 -291 -609 -36 -10  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -926 -291 -609 -36 -10  
EBIT / employee  -926 -291 -609 -36 -10  
Net earnings / employee  -14 255 39 -36 -10